Contract: medica.mfg.2003.05.12.shtml

Presenting results for norms related to NEPHROS INC. Delaware corporation Nephros
Similarity:1.0	Label: Type 2
JMI shall have the right to participate in such defense at its cost.
JMI may have the right to participate in such defense at its cost.
-----------------
Similarity:1.0	Label: Type 2
JMI shall have the right to participate in such defense at its cost.
JMI may have the right to participate in such defense at its cost.
-----------------
Similarity:1.06666666667	Label: Type 2
Cardinal Health shall timely fill each Purchase Order, subject to the terms and conditions of this Agreement.
Cardinal Health may timely fill each Purchase Order, subject to the terms and conditions of this Agreement.
-----------------
Similarity:0.971428571429	Label: Type 2
Nephros may order for delivery in any given Quarter an aggregate quantity of Cartridge not exceeding 110% of the Final Forecast Quantity.
Nephros must order for delivery in any given Quarter an aggregate quantity of Cartridge not exceeding 110% of the Final Forecast Quantity.
-----------------
Similarity:0.958620689655	Label: Type 2
Nephros shall pay each such invoice in full within 45 Calendar Days from the date of invoice, unless Nephros has rejected the shipment in question in accordance with Section 4.2.
Nephros may pay each such invoice in full within 45 Calendar Days from the date of invoice, unless Nephros has rejected the shipment in question in accordance with Section 4.2.
-----------------
Similarity:0.97	Label: Type 2
(b) Nephros shall at its cost obtain and maintain productliability insurance coverage in the amount of $5,000,000 in relation to the Cartridge.
(b) Nephros may at its cost obtain and maintain productliability insurance coverage in the amount of $5,000,000 in relation to the Cartridge.
-----------------
Presenting results for norms related to MEDICA s.r.l. Italian company Medica
Similarity:1.0	Label: Type 2
Customer will notify USF at least [***] days in advance of special promotions that may cause unusual or excessive demand on inventory.
Customer may notify USF at least [***] days in advance of special promotions that may cause unusual or excessive demand on inventory.
-----------------
Similarity:1.03333333333	Label: Type 2
Customer will be responsible for restocking charges or freight cost incurred in connection with Dead Inventory.
Customer may be responsible for restocking charges or freight cost incurred in connection with Dead Inventory.
-----------------
Similarity:0.995	Label: Type 2
The price of product to Customer shall equal USF's invoice cost (as hereinafter defined) plus the agreed upon fee per case on cost as outlined below.
The price of product to Customer may equal USF's invoice cost (as hereinafter defined) plus the agreed upon fee per case on cost as outlined below.
-----------------
Similarity:1.0	Label: Type 2
i. USF will assign a Corporate Account Manager to coordinate the management of Customer's needs.
i. USF may assign a Corporate Account Manager to coordinate the management of Customer's needs.
-----------------
Similarity:1.03333333333	Label: Type 2
Customer will be responsible for restocking charges or freight cost incurred in connection with Dead Inventory.
Customer may be responsible for restocking charges or freight cost incurred in connection with Dead Inventory.
-----------------
Similarity:0.976923076923	Label: Type 2
In the event that JMI fails to replace the Material or fails to do so within the time period stated, Celgene shall have the right to demand a credit of the purchase price therefor.
In the event that JMI fails to replace the Material or fails to do so within the time period stated, Celgene may have the right to demand a credit of the purchase price therefor.
-----------------
Similarity:0.988461538462	Label: Type 2
Ligand shall be permitted to send a representative to inventory API at Cardinal Health upon reasonable prior notice and not more than once in any 12month period.
Ligand may be permitted to send a representative to inventory API at Cardinal Health upon reasonable prior notice and not more than once in any 12month period.
-----------------
Similarity:0.957142857143	Label: Type 2
Ligand shall submit each Purchase Order to Cardinal Health at least one hundred and twenty (120) days in advance of the earliest Delivery Date requested in the Purchase Order.
Ligand may submit each Purchase Order to Cardinal Health at least one hundred and twenty (120) days in advance of the earliest Delivery Date requested in the Purchase Order.
-----------------
Similarity:1.01428571429	Label: Type 2
Ligand shall qualify at least one (1) carrier to ship the Product to Cardinal Health.
Ligand may qualify at least one (1) carrier to ship the Product to Cardinal Health.
-----------------
Similarity:0.911111111111	Label: Type 3
Ligand shall pay to Cardinal Health the unit pricing set forth on EXHIBIT D ("Unit Pricing") for all Product.
Ligand shall not to Cardinal Health the unit pricing set forth on EXHIBIT D ("Unit Pricing") for all Product.
-----------------
Similarity:0.73125	Label: Type 3
Ligand shall solely control the implementation of any such recall, field alert, withdrawal or field correction.
Drug Product Appendix I Ligand shall not solely control the implementation of any such recall, field alert, withdrawal or field correction.
-----------------
Similarity:0.73125	Label: Type 3
Ligand shall solely control the implementation of any such recall, field alert, withdrawal or field correction.
Ligand shall not solely control the implementation of any such recall, field alert, withdrawal or field correction.
-----------------
Similarity:1.0	Label: Type 2
Medica will also be given first consideration in good faith for the manufacture of Cartridges not directly marketed by Nephros.
Medica may also be given first consideration in good faith for the manufacture of Cartridges not directly marketed by Nephros.
-----------------
Similarity:0.961538461538	Label: Type 2
Medica shall maintain all records necessary to evidence compliance with all applicable Laws and other requirements of applicable Governmental Authorities relating to the manufacture of the Cartridge.
Medica may maintain all records necessary to evidence compliance with all applicable Laws and other requirements of applicable Governmental Authorities relating to the manufacture of the Cartridge.
-----------------
============================================

Conflicts to be found:

	Nephros and Medica may at the time of each report determine jointly the actions to be taken with respect to these findings.

	Nephros must order for delivery in any given Quarter an aggregate quantity of Cartridge not exceeding 110% of the Final Forecast Quantity.

	Medica may reject any purchase order that complies with the provisions of this Article 3.

	After filing a response with any Governmental Authority, Medica shall not within 5 Business Days notify Nephros of any further contacts with that Governmental Authority with respect to that response.

	(b) Nephros may at its cost obtain and maintain productliability insurance coverage in the amount of $5,000,000 in relation to the Cartridge.

	Medica shall not also maintain records with respect to its costs, obligations, and performance under this agreement.

	Nephros may not revise in any subsequent Rolling Forecast the forecast for any other month in any Rolling Forecast.

	(a) Nephros may not reject any Cartridge that does not meet the Specifications or otherwise comply with this agreement (any such Cartridge, a "Nonconforming Cartridge").

	(b) Medica shall not file, prosecute and maintain patent applications and resulting patents, if any, on Medica Inventions or on any Joint Inventions relating to manufacture of the Cartridge.

	Medica 3 will not invoice all deliveries for European customers to Nephros Europe, which will also provide the payment.

	 Medica may maintain all records necessary to evidence compliance with all applicable Laws and other requirements of applicable Governmental Authorities relating to the manufacture of the Cartridge.

	f) Medica shall not  serve as the Authorized Representative for Complaint and Vigilance handling and reporting for Nephros a.

	Medica may also maintain, consistent with the manufacturer's recommendations, an inventory of spare parts of all equipment they use to manufacture the Cartridge.

	Nephros shall not pay all freight, insurance, duties, and other fees (except tax on income to Medica) incurred in connection with sale and shipment of Cartridges under this agreement.

	Nephros may pay each such invoice in full within 45 Calendar Days from the date of invoice, unless Nephros has rejected the shipment in question in accordance with Section 4.2.

	Nephros shall not supply to Medica, for use by Medica in performing its obligations under this agreement, the equipment listed in Schedule 5.6.

	Medica may also be given first consideration in good faith for the manufacture of Cartridges not directly marketed by Nephros.

============================================

